Modulating T Cell Phenotype and Function to Treat Hypertension
Open Access
- 23 March 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 4 (4) , e534-e543
Abstract
Hypertension is the leading modifiable risk factor of worldwide morbidity and mortality because of its effects on cardiovascular and renal end-organ damage. Unfortunately, BP control is not sufficient to fully reduce the risks of hypertension, underscoring the need for novel therapies that address end-organ damage in hypertension. Over the past several decades, the link between immune activation and hypertension has been well established, but there are still no therapies for hypertension that specifically target the immune system. In this review, we describe the critical role played by T cells in hypertension and hypertensive end-organ damage and outline potential therapeutic targets to modulate T-cell phenotype and function in hypertension without causing global immunosuppression.Keywords
This publication has 104 references indexed in Scilit:
- Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac diseaseNature Genetics, 2011
- Genetic variants in novel pathways influence blood pressure and cardiovascular disease riskNature, 2011
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- Natural Regulatory T Cells Control Coronary Arteriolar Endothelial Dysfunction in Hypertensive MiceThe American Journal of Pathology, 2011
- mTOR regulates memory CD8 T-cell differentiationNature, 2009
- Enhancing CD8 T-cell memory by modulating fatty acid metabolismNature, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Genome-wide association study of blood pressure and hypertensionNature Genetics, 2009
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesNature Genetics, 2009
- Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cellsInternational Immunopharmacology, 2007